Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.52% | 196.99 | 1.2% | $490.69m | |
| GILD | Gilead Sciences, Inc. | -0.75% | 71.80 | 0.9% | $442.91m | |
| BIIB | Biogen Inc. | 0.37% | 316.71 | 1.3% | $345.99m | |
| ILMN | Illumina, Inc. | -2.22% | 310.20 | 3.5% | $333.80m | |
| CELG | Celgene Corporation | -0.98% | 79.82 | 1.2% | $320.64m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -2.23% | 173.45 | 1.9% | $231.00m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.22% | 383.06 | 2.6% | $221.24m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.10% | 122.56 | 2.0% | $215.73m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.94% | 133.80 | 16.4% | $167.53m | |
| A | Agilent Technologies, Inc. | -3.17% | 62.24 | 1.5% | $150.01m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.74% | 100.69 | 4.4% | $135.55m | |
| LGND | Ligand Pharmaceuticals Incorporated | -1.89% | 181.39 | 23.3% | $115.97m | |
| EXAS | Exact Sciences Corporation | 1.22% | 63.01 | 25.3% | $106.87m | |
| ECYT | Endocyte, Inc. | 0.15% | 23.56 | 2.1% | $96.01m | |
| NBIX | Neurocrine Biosciences, Inc. | -1.60% | 107.43 | 5.1% | $94.17m |
Company Profile
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.